RAS-INHIBITOREN

European patent · EP4413008 · In force

Register entry

Publication number
EP4413008
Application number
EP22798037
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 7, 2022
Published
Aug 14, 2024
Granted
Jun 24, 2026
Protection ends at the latest
Oct 6, 2042
Next annual fee due
Oct 31, 2026
IPC classes
C07D 519/00 (2006.01)
A61P 35/00 (2006.01)
A61K 47/50 (2017.01)
A61K 31/501 (2006.01)
Priority
US 202163254013 P 08.10.2021
PCT application
PCT/US2022/077784 07.10.2022
PCT publication
WO2023/060253 13.04.2023
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 25, 2026

    Agent entered

    Representative
    Stolmár & Partner Intellectual Property S.à.r.l., Bahnhofstrasse 11, 6210 Sursee

    Published in Swissreg on 25.09.2026

  2. Jun 24, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 24.06.2026

Parties

Inventor

BUCKL, Andreas

Redwood City, CA 94063, US

BURNETT, G., Leslie

Redwood City, CA 94063, US

CREGG, James

Redwood City, CA 94063, US

EDWARDS, Anne, V.

Redwood City, CA 94063, US

GILL, Adrian, L.

Redwood City, CA 94063, US

KNOX, John, E.

Redwood City, CA 94063, US

KOLTUN, Elena, S.

Redwood City, CA 94063, US

LIU, Yang

Redwood City, CA 94063, US

SEMKO, Christopher

Redwood City, CA 94063, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.